143.19
price up icon0.87%   1.23
after-market 시간 외 거래: 143.19
loading

Neurocrine Biosciences Inc 주식(NBIX)의 최신 뉴스

pulisher
09:11 AM

Neurocrine Biosciences CEO Gano Kyle sells $42591 in stock - Investing.com

09:11 AM
pulisher
12:00 PM

What Makes Neurocrine (NBIX) a New Strong Buy Stock - Yahoo Finance

12:00 PM
pulisher
11:09 AM

Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $179.00 - MarketBeat

11:09 AM
pulisher
09:54 AM

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus - Yahoo Finance

09:54 AM
pulisher
08:11 AM

Why Neurocrine Biosciences Inc. stock remains resilientJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com

08:11 AM
pulisher
07:07 AM

Is Neurocrine Biosciences Inc. stock trading near support levelsBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com

07:07 AM
pulisher
07:04 AM

Can Neurocrine Biosciences Inc. stock weather global recessionSwing Trade & Fast Momentum Stock Entry Tips - newser.com

07:04 AM
pulisher
05:31 AM

How Neurocrine Biosciences Inc. stock responds to policy changes2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com

05:31 AM
pulisher
04:53 AM

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Tredje AP fonden - MarketBeat

04:53 AM
pulisher
04:44 AM

Will Neurocrine Biosciences Inc. (NB3) stock boost dividends furtherEarnings Performance Report & Weekly Stock Performance Updates - newser.com

04:44 AM
pulisher
04:31 AM

Is Neurocrine Biosciences Inc. (NB3) stock attractive for dividend growthWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com

04:31 AM
pulisher
04:22 AM

What earnings revisions data tells us about Neurocrine Biosciences Inc.Quarterly Profit Report & AI Driven Price Forecasts - newser.com

04:22 AM
pulisher
03:38 AM

What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com

03:38 AM
pulisher
02:38 AM

Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyCPI Data & Stepwise Swing Trade Plans - newser.com

02:38 AM
pulisher
12:01 PM

Neurocrine Biosciences, Inc. (NBIX) Stock Forecasts - Yahoo! Finance Canada

12:01 PM
pulisher
Nov 03, 2025

Measuring Neurocrine Biosciences Inc.’s beta against major indices2025 Trading Volume Trends & Daily Profit Maximizing Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 22:02:17 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine Biosciences, Inc. (NBIX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 03, 2025
pulisher
Nov 03, 2025

Is Neurocrine Biosciences Inc. (NB3) stock vulnerable to rate hikes2025 Dividend Review & Verified Entry Point Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine taps China biotech for NLRP3 programs: Deals Report - biocentury.com

Nov 03, 2025
pulisher
Nov 03, 2025

Key facts: JP Morgan Raises Neurocrine Target to $179; TransThera Deal Worth $881.5M - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine Bio. stock price target raised to $147 by BMO Capital - Investing.com Canada

Nov 03, 2025
pulisher
Nov 03, 2025

What data driven models say about Neurocrine Biosciences Inc.’s futureWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying sector rotation models to Neurocrine Biosciences Inc.Market Volume Report & Risk Adjusted Swing Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How big funds are accumulating Neurocrine Biosciences Inc. (NB3) stockJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Neurocrine Biosciences (NBIX): Assessing Valuation After Strong Q3 Results and Pipeline Progress - simplywall.st

Nov 03, 2025
pulisher
Nov 03, 2025

Can Neurocrine Biosciences Inc. stock sustain revenue growth2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

What moving averages say about Neurocrine Biosciences Inc.Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

TransThera Sciences Sells NLRP3 Inhibitor License to Neurocrine Bioscience - MarketScreener

Nov 02, 2025
pulisher
Nov 02, 2025

Transthera Sciences (Nanjing) Inc announces collaboration with Neurocrine Biosciences Inc for NLRP3 inhibitors - MarketScreener

Nov 02, 2025
pulisher
Nov 02, 2025

Transthera Sciences (Nanjing) Inc Announces Collaboration With Neurocrine Biosciences Inc For NLRP3 Inhibitors - TradingView

Nov 02, 2025
pulisher
Nov 02, 2025

TransThera Sciences Partners with Neurocrine for NLRP3 Inhibitors Development - TipRanks

Nov 02, 2025
pulisher
Nov 02, 2025

How risky is Neurocrine Biosciences Inc. stock nowEarnings Miss & Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

1,945 Shares in Neurocrine Biosciences, Inc. $NBIX Purchased by Daymark Wealth Partners LLC - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

What analysts say about Neurocrine Biosciences Inc stockMarket Timing Techniques & Explosive Trading Portfolio - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Neurocrine Biosciences, Inc. (NBIX) Stock forecasts - Yahoo! Finance UK

Nov 01, 2025
pulisher
Nov 01, 2025

Is It Time to Lock in Profits on Winsol Engineers Limited StockPrice Volatility Patterns & Exceptional Trading Strategies - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Cantor Fitzgerald Brokers Raise Earnings Estimates for NBIX - MarketBeat

Nov 01, 2025
$10.49
price down icon 0.38%
drug_manufacturers_specialty_generic RDY
$13.47
price up icon 0.45%
$22.50
price down icon 1.53%
$42.79
price down icon 3.60%
$437.33
price down icon 0.30%
자본화:     |  볼륨(24시간):